Log In
BCIQ
Print this Print this
 

AXP1275

  Manage Alerts
Collapse Summary General Information
Company Axikin Pharmaceuticals Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat atopic asthma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today